JP2023516595A5 - - Google Patents

Info

Publication number
JP2023516595A5
JP2023516595A5 JP2022550927A JP2022550927A JP2023516595A5 JP 2023516595 A5 JP2023516595 A5 JP 2023516595A5 JP 2022550927 A JP2022550927 A JP 2022550927A JP 2022550927 A JP2022550927 A JP 2022550927A JP 2023516595 A5 JP2023516595 A5 JP 2023516595A5
Authority
JP
Japan
Application number
JP2022550927A
Other languages
Japanese (ja)
Other versions
JP2023516595A (ja
JPWO2021174124A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/020089 external-priority patent/WO2021174124A1/en
Publication of JP2023516595A publication Critical patent/JP2023516595A/ja
Publication of JP2023516595A5 publication Critical patent/JP2023516595A5/ja
Publication of JPWO2021174124A5 publication Critical patent/JPWO2021174124A5/ja
Pending legal-status Critical Current

Links

JP2022550927A 2020-02-27 2021-02-26 Cd20を結合する二量体抗原受容体(dar) Pending JP2023516595A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202062982348P 2020-02-27 2020-02-27
US62/982,348 2020-02-27
US202063089869P 2020-10-09 2020-10-09
US63/089,869 2020-10-09
PCT/US2021/020089 WO2021174124A1 (en) 2020-02-27 2021-02-26 Dimeric antigen receptors (dar) that bind cd20

Publications (3)

Publication Number Publication Date
JP2023516595A JP2023516595A (ja) 2023-04-20
JP2023516595A5 true JP2023516595A5 (https=) 2024-03-06
JPWO2021174124A5 JPWO2021174124A5 (https=) 2024-03-06

Family

ID=77490527

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022550927A Pending JP2023516595A (ja) 2020-02-27 2021-02-26 Cd20を結合する二量体抗原受容体(dar)

Country Status (6)

Country Link
US (1) US20230061838A1 (https=)
EP (1) EP4110829A4 (https=)
JP (1) JP2023516595A (https=)
CN (1) CN115461377A (https=)
CA (1) CA3169158A1 (https=)
WO (1) WO2021174124A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116655805B (zh) * 2023-05-31 2024-03-08 四川大学华西医院 一种靶向her2阳性肿瘤的新型car-t细胞及制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002327164A1 (en) * 2001-01-29 2002-12-09 Idec Pharmaceuticals Corporation Engineered tetravalent antibodies and methods of use
CN108395482B (zh) * 2017-02-08 2021-02-05 西比曼生物科技(香港)有限公司 一种靶向cd20抗原嵌合抗原受体的构建及其工程化t细胞的活性鉴定
TW201900672A (zh) * 2017-03-27 2019-01-01 瑞士商赫孚孟拉羅股份公司 改良之抗原結合受體型式
JP2021508246A (ja) * 2017-12-21 2021-03-04 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト 新規抗原結合部分の特異性試験のためのcar−t細胞アッセイ
SG11202008568WA (en) * 2018-03-09 2020-10-29 Sorrento Therapeutics Inc Dimeric antigen receptors (dar)

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
JP2022546577A5 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
JP2023516595A5 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)